Victoria Sanz-Moreno: key facts
- Kind of voice
- Academic
- Role
- Professor at The Institute of Cancer Research, leads the Cytoskeleton and Cancer Metastasis group
- Quoted on
- Cancer
- Tracked press citations
- 3 (2 with a linkable article)
- Most recently quoted
- 30 Sept 2026
- First quoted
- 8 Aug 2026
“Professor Sanz-Moreno is an international expert in metastatic cancers including melanoma and breast cancer, and leads the ICR's Cytoskeleton and Cancer Metastasis group, investigating the hallmarks and vulnerabilities in cancer cells that have spread elsewhere in the body, with the aim of improving treatment for patients with advanced breast cancer as well as other cancers.”
What Victoria Sanz-Moreno has said
“It was surprising that blocking a single receptor not only reduced the spread of melanoma but also appeared to restore the effectiveness of immunotherapy in resistant tumours. The discovery that NGFR controls resistance through the MLC2 pathway provides an unexpected new target for treating advanced melanoma.”
Professor of Cancer Cell and Metastasis Biology at the ICR · Cancer · 30 Sept 2026 · Newly discovered mechanism behind cancer spread points to potential new target for tackling advanced melanoma ↗
Where Victoria Sanz-Moreno has been quoted
- “Providing hope is everything to a cancer patient” – Rhonda’s storyicr.ac.uk · 30 Sept 2026
- Newly discovered mechanism behind cancer spread points to potential new target for tackling advanced melanomaicr.ac.uk · 30 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.